Creoptix

Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from …

Creoptix, a Switzerland-based company focused on next-generation bioanalytical instruments, announced that it has signed an agreement with oneservice,…

Creoptix and 2bind have signed a technology-service partnership, which enables both parties to continue offering customers the highest quality…

Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, announced the appointment of Line Stigen Raquet as…

Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, announced that is has raised CHF 8 million in the first…